KFF Examines Key Considerations for the Implementation of Insurance Coverage for Over-the-Counter Contraceptives

With federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives. These contraceptives include Opill, the first daily oral contraceptive pill to receive FDA approval for…More

from KFF https://ift.tt/zvO0Xdr